U-Blot® Research Grade ItepekimabCat. No. WA3016$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade ItepekimabCat. No. WA3016
U-Blot® Research Grade itanistomigCat. No. WA3015
U-Blot® Research Grade isuventatugCat. No. WA3014
U-Blot® Research Grade IstiratumabCat. No. WA3013
U-Blot® Research Grade IspectamabCat. No. WA3012
U-Blot® Research Grade IsecarosmabCat. No. WA3011
U-Blot® Research Grade iscastobartCat. No. WA3010
U-Blot® Research Grade IscalimabCat. No. WA3009
U-Blot® Research Grade IsatuximabCat. No. WA3008
U-Blot® Research Grade IratumumabCat. No. WA3007
U-Blot® Research Grade ipsoprubartCat. No. WA3006
U-Blot® Research Grade IpilimumabCat. No. WA3005